Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Lewis

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|July 2, 2024
Reduction of Z alpha-1 antitrypsin polymers in human iPSC-hepatocytes and mice by LRRK2 inhibitorsDeniz Kent, Soon Seng Ng, Adam M Syanda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2021
Dissecting the Phenotype and Genotype of PLA2G6-Related ParkinsonismFrancesca Magrinelli, Sahil Mehta, Giulia Di Lazzaro, et al.
Brain : a Journal of Neurology|May 25, 2016
Genetic and phenotypic characterization of complex hereditary spastic paraplegiaEleanna Kara, Arianna Tucci, Claudia Manzoni, et al.
Human Molecular Genetics|November 1, 2016
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritanceSteven J Lubbe, Valentina Escott-Price, J Raphael Gibbs, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Brain : a Journal of Neurology|September 8, 2022
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 lociMarc P M Soutar, Daniela Melandri, Benjamin O'Callaghan, et al.
Cell Reports|June 9, 2021
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synucleinEleanna Kara, Alessandro Crimi, Anne Wiedmer, et al.
Plos One|September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease researchSelina Wray, Matthew Self, , et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
<i>PSMF1</i> variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathwaysFrancesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Nature Communications|April 15, 2026
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethalityFrancesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|July 2, 2024
Reduction of Z alpha-1 antitrypsin polymers in human iPSC-hepatocytes and mice by LRRK2 inhibitorsDeniz Kent, Soon Seng Ng, Adam M Syanda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2021
Dissecting the Phenotype and Genotype of PLA2G6-Related ParkinsonismFrancesca Magrinelli, Sahil Mehta, Giulia Di Lazzaro, et al.
Brain : a Journal of Neurology|May 25, 2016
Genetic and phenotypic characterization of complex hereditary spastic paraplegiaEleanna Kara, Arianna Tucci, Claudia Manzoni, et al.
Human Molecular Genetics|November 1, 2016
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritanceSteven J Lubbe, Valentina Escott-Price, J Raphael Gibbs, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Brain : a Journal of Neurology|September 8, 2022
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 lociMarc P M Soutar, Daniela Melandri, Benjamin O'Callaghan, et al.
Cell Reports|June 9, 2021
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synucleinEleanna Kara, Alessandro Crimi, Anne Wiedmer, et al.
Plos One|September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease researchSelina Wray, Matthew Self, , et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
<i>PSMF1</i> variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathwaysFrancesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Nature Communications|April 15, 2026
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethalityFrancesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Pageof 12